Frequency and Pattern of Noninfectious Adverse Transfusion Reactions at a Tertiary Care Hospital in Korea
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Background: Although transfusion is a paramount life-saving therapy, there are multiple potential significant risks. Therefore, all adverse transfusion reaction (ATR) episodes require close monitoring. Using the computerized reporting system, we assessed the frequency and pattern of non-infectious ATRs. Methods: We analyzed two-year transfusion data from electronic medical records retrospectively. From March 2013 to February 2015, 364,569 units of blood were transfused. Of them, 334,582 (91.8%) records were identified from electronic nursing records. For the confirmation of ATRs by blood bank physicians, patients’ electronic medical records were further evaluated. Results: According to the nursing records, the frequency of all possible transfusion-related events was 3.1%. After the blood bank physicians’ review, the frequency was found to be 1.2%. The overall frequency of febrile non-hemolytic transfusion reactions (FNHTRs) to red blood cells (RBCs), platelet (PLT) components, and fresh frozen plasmas (FFPs) were 0.9%, 0.3%, and 0.2%, respectively, and allergic reactions represented 0.3% (RBCs), 0.9% (PLTs), and 0.9% (FFPs), respectively. The pre-storage leukocyte reduction significantly decreased the frequency of FNHTRs during the transfusion of RBCs (P<0.01) or PLTs (P≒0.01). Conclusions: The frequency of FNHTRs, allergic reactions, and “no reactions” were 22.0%, 17.0%, and 60.7%, respectively. Leukocyte-reduction was associated with a lower rate of FNHTRs, but not with that of allergic reactions. The development of an effective electronic reporting system of ATRs is important in quantifying transfusion-related adverse events. This type of reporting system can also accurately identify the underlying problems and risk factors to further the quality of transfusion care for patients.
Abstract
Background: Although transfusion is a paramount life-saving therapy, there are multiple potential significant risks. Therefore, all adverse transfusion reaction (ATR) episodes require close monitoring. Using the computerized reporting system, we assessed the frequency and pattern of non-infectious ATRs. Methods: We analyzed two-year transfusion data from electronic medical records retrospectively. From March 2013 to February 2015, 364,569 units of blood were transfused. Of them, 334,582 (91.8%) records were identified from electronic nursing records. For the confirmation of ATRs by blood bank physicians, patients’ electronic medical records were further evaluated. Results: According to the nursing records, the frequency of all possible transfusion-related events was 3.1%. After the blood bank physicians’ review, the frequency was found to be 1.2%. The overall frequency of febrile non-hemolytic transfusion reactions (FNHTRs) to red blood cells (RBCs), platelet (PLT) components, and fresh frozen plasmas (FFPs) were 0.9%, 0.3%, and 0.2%, respectively, and allergic reactions represented 0.3% (RBCs), 0.9% (PLTs), and 0.9% (FFPs), respectively. The pre-storage leukocyte reduction significantly decreased the frequency of FNHTRs during the transfusion of RBCs (P<0.01) or PLTs (P≒0.01). Conclusions: The frequency of FNHTRs, allergic reactions, and “no reactions” were 22.0%, 17.0%, and 60.7%, respectively. Leukocyte-reduction was associated with a lower rate of FNHTRs, but not with that of allergic reactions. The development of an effective electronic reporting system of ATRs is important in quantifying transfusion-related adverse events. This type of reporting system can also accurately identify the underlying problems and risk factors to further the quality of transfusion care for patients.
참고문헌 (16)
- Sahu S, "Adverse events related to blood transfusion", Indian J Anaesth, 58, pp.543~551 (2014)
- Hendrickson JE, "Noninfectious serious hazards of transfusion", Anesth Analg, 108, pp.759~769 (2009)
- Kato H, "A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion history", Vox Sang, 108, pp.243~250 (2015)
- Tinegate H, "Guideline on the investigation and management of acute transfusion reactions. Prepared by the BCSH Blood Transfusion Task Force", Br J Haematol, 159, pp.143~153 (2012)
- Fry JL, "Transfusion premedication to prevent acute transfusion reactions: a retrospective observational study to assess current practices", Transfusion, 50, pp.1722~1730 (2010)
- Mazzei CA, "Technical manual", pp.665~696 (2014), American Association of Blood Banks
- "National Healthcare Safety Network Biovigilance Component Hemovigilance Module Surveillance Protocol c.2.1.3"[URL]
- Yeh SP, "A well-designed online transfusion reaction reporting system improves the estimation of transfusion reaction incidence and quality of care in transfusion practice", Am J Clin Pathol, 136, pp.842~847 (2011)
- de Vries RR, "Haemovigilance: an effective tool for improving transfusion practice", Vox Sang, 100, pp.60~67 (2011)
- Uhlmann EJ, "Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions", Transfusion, 41, pp.997~1000 (2001)
- Yazer MH, "The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC", Transfusion, 44, pp.10~15 (2004)
- Bilgin YM, "Clinical effects of leucoreduction of blood transfusions", Neth J Med, 69, pp.441~450 (2011)
- Harvey AR, "Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012", Transfusion, 55, pp.709~718 (2015)
- Wang RR, "Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets", Am J Clin Pathol, 138, pp.255~259 (2012)
- Paglino JC, "Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction", Transfusion, 44, pp.16~24 (2004)
- Dasararaju R, "Adverse effects of transfusion", Cancer Control, 22, pp.16~25 (2015)